63034s Search Results


93
Cell Signaling Technology Inc collagen iii
Fig. 3. LQF alleviated TAC-induced cardiac fibrosis in vivo. (A) A four-week longitudinal morphology of mice hearts after sham or TAC surgery (n = 5, scale bar = 500 µm). (B, C) Representative images of Sirius red staining and Masson’s trichrome staining in hearts following sham or TAC surgery for 4 weeks (n = 5, scale bar = 20 µm). (D, E) Quantification of the interstitial fibrotic area in mice at 4 weeks after the sham or TAC surgery (n = 5 for each group). (F, G) Quantification of the perivascular fibrotic area in mice at 4 weeks following the sham or TAC surgery (n = 5 for each group). (H~J) Representative WB image and quantitative analysis of cardiac fibrosis-related proteins, including Col I and Col <t>III</t> (n = 3). (Data are presented as mean ± SEM. ***p < 0.001 vs. sham; ****p < 0.0001 vs. sham; #p < 0.05 vs. TAC; ##p < 0.01 vs. TAC; ###p < 0.001 vs. TAC; ####p < 0.0001 vs. TAC. ns, no significant.).
Collagen Iii, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/63034s/COL3A1+XP+Rabbit+mAb/pm38295662-163-21-24
Average 93 stars, based on 1 article reviews
collagen iii - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 3. LQF alleviated TAC-induced cardiac fibrosis in vivo. (A) A four-week longitudinal morphology of mice hearts after sham or TAC surgery (n = 5, scale bar = 500 µm). (B, C) Representative images of Sirius red staining and Masson’s trichrome staining in hearts following sham or TAC surgery for 4 weeks (n = 5, scale bar = 20 µm). (D, E) Quantification of the interstitial fibrotic area in mice at 4 weeks after the sham or TAC surgery (n = 5 for each group). (F, G) Quantification of the perivascular fibrotic area in mice at 4 weeks following the sham or TAC surgery (n = 5 for each group). (H~J) Representative WB image and quantitative analysis of cardiac fibrosis-related proteins, including Col I and Col III (n = 3). (Data are presented as mean ± SEM. ***p < 0.001 vs. sham; ****p < 0.0001 vs. sham; #p < 0.05 vs. TAC; ##p < 0.01 vs. TAC; ###p < 0.001 vs. TAC; ####p < 0.0001 vs. TAC. ns, no significant.).

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Article Title: LuQi formula attenuates Cardiomyocyte ferroptosis via activating Nrf2/GPX4 signaling axis in heart failure.

doi: 10.1016/j.phymed.2024.155357

Figure Lengend Snippet: Fig. 3. LQF alleviated TAC-induced cardiac fibrosis in vivo. (A) A four-week longitudinal morphology of mice hearts after sham or TAC surgery (n = 5, scale bar = 500 µm). (B, C) Representative images of Sirius red staining and Masson’s trichrome staining in hearts following sham or TAC surgery for 4 weeks (n = 5, scale bar = 20 µm). (D, E) Quantification of the interstitial fibrotic area in mice at 4 weeks after the sham or TAC surgery (n = 5 for each group). (F, G) Quantification of the perivascular fibrotic area in mice at 4 weeks following the sham or TAC surgery (n = 5 for each group). (H~J) Representative WB image and quantitative analysis of cardiac fibrosis-related proteins, including Col I and Col III (n = 3). (Data are presented as mean ± SEM. ***p < 0.001 vs. sham; ****p < 0.0001 vs. sham; #p < 0.05 vs. TAC; ##p < 0.01 vs. TAC; ###p < 0.001 vs. TAC; ####p < 0.0001 vs. TAC. ns, no significant.).

Article Snippet: The primary antibodies comprised SLC7A11 (26,864–1-AP, Proteintech, China); GPX4 (67,763–1-Ig, Proteintech, China); Nrf2 (16,396–1-AP, Proteintech, China); Collagen I (14,695–1-AP, Proteintech, China); Collagen III (63,034, CST, USA); HO-1 (43,966.

Techniques: In Vivo, Staining